0 results for 'DePuy Orthopaedics, Inc.'
Top 100 Verdicts: Appeal to Jurors' Emotions
A multi-billion dollar verdict involving breaches of fiduciary duty scores the top award in the 2017 list by NLJ-affiliate VerdictSearch.NJ Mass Torts Saw Shake-Ups, Settlements, Key Rulings in 2014
New Jersey's pharmaceutical and biotech industry has long made the state a hub for mass-tort litigation, with thousands of cases pending at any one time against New Jersey-based companies like Johnson & Johnson, Stryker Orthopaedics, Organon and their subsidiaries.Case Filings Dip in Hip Replacement MDL
In the month after a take-nothing verdict, fewer plaintiffs filed cases against Johnson & Johnson and its subsidiary in Dallas federal court.Case Filings Dip in Hip Replacement MDL
In the month after a take-nothing verdict, fewer plaintiffs filed cases against Johnson & Johnson and its subsidiary in Dallas federal court.Hip Replacement Device Defendants Win Take-Nothing Verdict
On Oct. 23, a jury issued a favorable verdict for defendants Depuy Orthopedics Inc., a subsidiary of Johnson & Johnson, after an almost two-month trial in the first bellwether case in the hip replacement device multidistrict litigation in Dallas federal court.Hip Replacement Device Defendants Win Take-Nothing Verdict
On Oct. 23, a jury issued a favorable verdict for defendants Depuy Orthopedics, Inc., a subsidiary of Johnson & Johnson, after an almost two-month trial in the first bellwether case in the hip replacement device multidistrict litigation in Dallas federal court.Firms Feast on Yet Another Health Care Deal
Medical device maker Zimmer Holdings has agreed to pay $13.35 billion to acquire rival Biomet Inc.Implant Makers Pay $310M as Part of Settlement of Kickback Claims
The five companies that provide nearly all the replacement hips and knees used in America have agreed to pay $310 million and accept federal monitors to settle government claims of doctor kickbacks. The companies allegedly paid orthopedic surgeons "exorbitant" amounts to be consultants and use their products exclusively. Criminal charges against four of the companies will be dismissed if they adhere to the settlement requirements; the fifth company entered a non-prosecution agreement.Draconian Consequences of the DPA
James M. Keneally, a partner at Kelley Drye & Warren, writes that while a deferred prosecution agreement is obviously preferable to the death sentence that can be inflicted by an indictment and conviction, it can compel a corporation to make admissions and adopt positions that can have a deleterious effect on its ability to defend itself in subsequent civil and regulatory litigation. However, some recent DPAs indicate that under the right circumstances, the corporation might be able to avoid admitting to the conduct alleged by the government.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Why Embracing Change Is Essential for Your Legal Department
Brought to you by DiliTrust
Download Now
International Export and Trade Assistance State Law Survey
Brought to you by LexisNexis®
Download Now
How This Personal Injury Firm Reduced Client Intake Time by 80%
Brought to you by PracticePanther
Download Now
The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation
Brought to you by Erase.com
Download Now